Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2157 stock hub

HKG/2157 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/2157is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
9.5B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/2157
In the news

Latest news · HKG/2157

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/E31.6
P25 10.7P50 17.9P75 38.5
ROE25.3
P25 -14.7P50 2P75 9.4
ROIC1.8
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/2157 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
187
Groups with data
11
Currency
CNY
Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
HK
Employees
710
Employees Change
212%
Employees Change Percent
42.57
Enterprise value
HKD 9.5B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE100004SM4
Last refreshed
2026-05-10
Market cap
HKD 9.5B
Price
HKD 5.24
Price currency
HKD
Rev Per Employee
1,465,256.06x
Sector
Healthcare
Sic
2836
Symbol
hkg/2157
Website
https://www.lepubiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
3.08%
EV Earnings
32.82x
EV/EBITDA
76.6x
EV/FCF
-148.81x
EV/Sales
9.17x
FCF yield
-0.68%
P/B ratio
6.23x
P/E ratio
31.62x
P/S ratio
9.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
2.77%
EBITDA Margin
11.27%
Gross margin
90.42%
Gross Profit
HKD 940.6M
Gross Profit Growth
36.5%
Gross Profit Growth Q
125.05%
Gross Profit Growth3 Y
73.62%
Gross Profit Growth5 Y
39.26%
Net Income
HKD 290.8M
Net Income Growth Quarters
2%
Net Income Growth Years
1%
Pretax Margin
27.88%
Profit Margin
27.96%
Profit Per Employee
HKD 409,646
Profitable Years
1
ROA
0.6
Roa5y
-12.71
ROCE
1.34
ROE
25.32
Roe5y
-39.95
ROIC
1.76
Roic5y
-47.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
12.46%
Cagr3y
-1.66%
EPS Growth Quarters
2
EPS Growth Years
1
Revenue Growth
154.18x
Revenue Growth Q
99.96x
Revenue Growth Quarters
3x
Revenue Growth Years
3x
Revenue Growth3 Y
65.81x
Revenue Growth5 Y
40.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
HKD 0.35
Assets
HKD 3.4B
Cash
HKD 1.1B
Current Assets
HKD 1.3B
Current Liabilities
HKD 1.3B
Debt
HKD 1.2B
Debt EBITDA
HKD 8.9
Debt Equity
HKD 0.78
Debt FCF
HKD -18.46
Equity
HKD 1.5B
Interest Coverage
0.92
Liabilities
HKD 1.9B
Long Term Assets
HKD 2.1B
Long Term Liabilities
HKD 594.6M
Net Cash
HKD -115.8M
Net Cash By Market Cap
HKD -1.22
Net Debt EBITDA
HKD 0.99
Net Debt Equity
HKD 0.08
Tangible Book Value
HKD 985.1M
Tangible Book Value Per Share
HKD 0.55
WACC
2.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.98
Inventory Turnover
2.4
Net Working Capital
HKD -212.8M
Quick ratio
0.91
Working Capital
HKD -22M
Working Capital Turnover
HKD -4.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-3.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
12.45%
200-day SMA
6.31
3Y total return
-4.9%
50-day SMA
5.22
50-day SMA vs 200-day SMA
50under200
All Time High
31.8
All Time High Change
-83.52%
All Time High Date
2022-09-09
All Time Low
2.16
All Time Low Change
142.59%
All Time Low Date
2024-08-23
ATR
0.31
Beta
-0.41
Beta1y
0.79
Beta2y
0.14
Ch YTD
5.43
High
5.3
High52
10.5
High52 Date
2025-08-25
High52ch
-50.1%
Low
5.15
Low52
3.9
Low52 Date
2026-03-04
Low52ch
34.36%
Ma50ch
0.31%
Price vs 200-day SMA
-16.9%
RSI
44.08
RSI Monthly
50.4
RSI Weekly
47.33
Sharpe ratio
0.46x
Sortino ratio
0.95
Total Return
-3.82%
Tr YTD
5.43
Tr1m
-14.8%
Tr1w
2.75%
Tr3m
11.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
HKD 28.8M
Operating margin
2.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
938,493,183%
Net Borrowing
250,856,495.1
Shares Insiders
29%
Shares Institutions
6.51%
Shares Out
1,804,439,838
Shares Qo Q
5.2%
Shares Yo Y
3.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
HKD -64.1M
Average Volume
11,257,249.15x
Bv Per Share
0.85
CAPEX
HKD -50.5M
Ch1m
-14.8
Ch1w
2.75
Ch1y
12.45
Ch3m
11.25
Ch3y
-4.9
Ch6m
-9.97
Change
0.19%
Change From Open
-1.13
Close
5.23
Days Gap
1.34
Depreciation Amortization
91,506,654.8
Dollar Volume
29,172,128
Earnings Date
2026-03-25
EBIT
HKD 28.8M
EBITDA
HKD 117.3M
EPS
HKD 0.17
F Score
5
FCF
HKD -64.1M
FCF EV Yield
-0.67x
FCF Per Share
HKD -0.04
Financing CF
625,334,816
Fiscal Year End
December
Founded
2,018
Goodwill
60,613,672.8
Graham Number
1.78543
Graham Upside
-65.93
Income Tax
HKD 1.9M
Investing CF
-116,867,332
Is Primary Listing
1
Last Earnings Date
2026-03-25
Last Report Date
2025-12-31
Ma150
5.59
Ma150ch
-6.26%
Ma20
5.66
Ma20ch
-7.39%
Net CF
502,705,353
Open
5.3
Position In Range
60
Ppne
1,183,133,152.5
Price Date
2026-05-08
Price EBITDA
HKD 80.63
Ptbv Ratio
9.6
Relative Volume
0.48x
Revenue
1,040,331,804x
Tax By Revenue
0.19x
Tax Rate
0.67%
Tr6m
-9.97%
Volume
5,567,200
Z Score
2.26
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/2157 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2157 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+12.4%
S&P 500 1Y: n/a
3Y total return
-4.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HKG/2157?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.5%
Share of float held by funds and institutions
Insider ownership
+29.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+3.8%
Negative means the company is buying back shares.
Technical

HKG/2157 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.1
Neutral momentum band
Price vs 200-day MA
-16.9%
50/200-day relationship not available
Beta (5Y)
-0.41
Less volatile than the market
Sharpe ratio
0.46
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/2157

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2157 stock rating?

hkg/2157 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2157 analysis?

The full report lives at /stocks/hkg/2157/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2157?

The latest report frames hkg/2157 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2157 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.